Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Biomarin Pharmaceutical (BMRN) Q4 2021 Earnings
BMRN
27
Oct
Confirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-0.25
-0.13
-0
0.12
Details
Expected EPS
-0.25
Actual EPS
-0.2
Surprise EPS
0.05
Surprise Percent
+20%
Description
Biomarin Pharmaceutical (BMRN) has reported earnings of -0.2 per share for Q4 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login